Invention Grant
- Patent Title: Pyrimidine inhibitors of PKTK2
- Patent Title (中): PKTK2的嘧啶抑制剂
-
Application No.: US12784813Application Date: 2010-05-21
-
Publication No.: US08410126B2Publication Date: 2013-04-02
- Inventor: Ioannis Sapountzis , Daniel Kuhn , Heinz Stadtmueller
- Applicant: Ioannis Sapountzis , Daniel Kuhn , Heinz Stadtmueller
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Alan R. Stempel
- Priority: EP09161496 20090529; EP10161628 20100430
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/505
Abstract:
Compounds of general formula (1) wherein A, B, R1 to R5, Rx m, n and p are defined as described in the specification, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and the use thereof [as] medicaments.
Public/Granted literature
- US20110130401A1 NEW CHEMICAL COMPOUNDS Public/Granted day:2011-06-02
Information query
IPC分类:
